Treatment Decision-Making for Leptomeningeal Metastasis After TKI Resistance in EGFR-Mutant Lung Cancer: A Comprehensive Review on Staging, Resistance Patterns, and Multimodal Interventions - Top-Institutions - MDSpire

Treatment Decision-Making for Leptomeningeal Metastasis After TKI Resistance in EGFR-Mutant Lung Cancer: A Comprehensive Review on Staging, Resistance Patterns, and Multimodal Interventions

  • By

  • Song, Guo-qiang

  • He, Tian Li

  • Ji, Ke-jie

  • Duan, Yi-meng

  • Hu, Guo-qiang

  • April 30, 2026

  • 0 min

Share

Top Institutions in Oncology

Brief introduction explaining scope and methodology.

  • #1

    NYU Grossman School of Medicine
    NYU Grossman School of Medicine

    New York, NY

    Key Differentiators

    • Oncology

  • #2

    The University of Texas MD Anderson Cancer Center
    The University of Texas MD Anderson Cancer Center

    Houston, TX

    Key Differentiators

    • Oncology

  • #3

    National Taiwan University College of Medicine
    National Taiwan University College of Medicine

    Taipei, Taiwan

    Key Differentiators

    • Oncology

  • #4

    Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute
    Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute

    Boston, MA

    Key Differentiators

    • Oncology

Original Source(s)

Treatment Decision-Making for Leptomeningeal Metastasis After TKI Resistance in EGFR-Mutant Lung Cancer: A Comprehensive Review on Staging, Resistance Patterns, and Multimodal Interventions

  • by Song, Guo-qiang , He, Tian Li , Ji, Ke-jie , Duan, Yi-meng , Hu, Guo-qiang

  • April 30, 2026

Related Content

Outcomes of critically ill pediatric patients after haploidentical stem cell transplantation

Antibody-Drug Conjugates for Locally Advanced and Metastatic Urothelial Carcinoma: A Systematic Review and

Icaritin plus TACE improves survival in advanced HCC with macrovascular invasion: a multicenter cohort study